Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort

Journal of Psychiatric Research
Benno G SchimmelmannP Conus

Abstract

To assess the impact of duration of untreated psychosis (DUP) on baseline and 18-month follow-up characteristics controlling for relevant confounders in an epidemiological first-episode psychosis (FEP) cohort. The Early Psychosis Prevention and Intervention Centre (EPPIC) in Australia admitted 786 FEP patients from January 1998 to December 2000. Data were collected from medical files using a standardized questionnaire. Data from 636 patients were analyzed. Median DUP was 8.7 weeks. Longer DUP was associated with worse premorbid functioning (p<0.001), higher rate of schizophrenia-spectrum disorders (p<0.001), and younger age at onset of psychosis (p=0.004). Longer DUP was not associated with baseline variables but with a lower rate of remission of positive symptoms (p<0.001) and employment/occupation (p<0.001), a higher rate of persistent substance use (p=0.015), worse illness severity (p<0.001) and global functioning (p<0.001) at follow-up after controlling for relevant confounders, explaining approximately 5% of variance of remission of positive symptoms (p<0.001) in the total sample and 3% in schizophrenia-spectrum disorders excluding bipolar I disorder (p=0.002). Outcome was significantly worse when DUP exceeded 1-3 months. ...Continue Reading

References

Jan 1, 1990·Schizophrenia Bulletin·P D McGorryB S Singh
Jan 1, 1982·Schizophrenia Bulletin·H E Cannon-SpoorR J Wyatt
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·T R BarnesE M Joyce
Apr 6, 2001·Lancet·B C Ho, N C Andreasen
Oct 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·R M NormanA K Malla
Jan 23, 2003·Psychological Medicine·S M HarriganH Krstev
Feb 6, 2004·Archives of General Psychiatry·Ingrid MelleThomas McGlashan
Mar 3, 2004·Schizophrenia Bulletin·Matcheri S KeshavanJohn A Sweeney
Mar 3, 2004·The American Journal of Psychiatry·Delbert G RobinsonRobert M Bilder
May 18, 2004·The Australian and New Zealand Journal of Psychiatry·N Srinivasan TirupatiPadmavati Raman
Jul 5, 2005·Acta Psychiatrica Scandinavica·M LambertB G Schimmelmann
Jul 12, 2005·Schizophrenia Research·Meredith G HarrisPatrick D McGorry
Jul 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Trevor BallageerRaj Haricharan
Aug 2, 2005·The British Journal of Psychiatry. Supplement·Jean Addington, John Gleeson
Aug 2, 2005·The British Journal of Psychiatry. Supplement·Lone PetersenPer Jørgensen
Nov 2, 2005·The Journal of Clinical Psychiatry·Benno G SchimmelmannMartin Lambert
Mar 7, 2006·Psychological Medicine·Ashok MallaRaj Haricharan
Apr 28, 2006·Acta Psychiatrica Scandinavica·A WunderinkD Wiersma
Jun 8, 2006·Psychological Medicine·N M MenezesR B Zipursky
Jul 20, 2006·The Journal of Clinical Psychiatry·Lena FlycktJohan Cullberg
Jul 26, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Benno Graf SchimmelmannMartin Lambert
Aug 26, 2006·Schizophrenia Research·Brendan P MurphyPatrick D McGorry
Sep 14, 2006·Acta Psychiatrica Scandinavica·H MengD Bürgin
Jun 15, 2007·Acta Psychiatrica Scandinavica·E SimonsenT McGlashan
Jul 14, 2007·Schizophrenia Research·Ross M G NormanRahul Manchanda

❮ Previous
Next ❯

Citations

Apr 25, 2012·European Child & Adolescent Psychiatry·Benno G Schimmelmann, Frauke Schultze-Lutter
Jul 10, 2008·The Australian and New Zealand Journal of Psychiatry·Katherine I MorleyDebra L Foley
Jun 1, 2009·Acta Neuropsychiatrica·Andrea PolariPhilippe Conus
Apr 29, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Andrzej CechnickiAnna Bielańska
Feb 23, 2010·Indian Journal of Psychiatry·Amresh Shrivastava
Oct 16, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marta Rapado-CastroOlivia M Dean
Mar 13, 2014·Schizophrenia Bulletin·Chantal MichelFrauke Schultze-Lutter
Mar 19, 2013·BMC Psychiatry·Sue M CottonPhilippe Conus
May 28, 2010·International Review of Psychiatry·Brendan P Murphy
Jun 28, 2014·Expert Opinion on Investigational Drugs·Corinna Klein, Anton Bespalov
Jul 22, 2014·Schizophrenia Research·S Y ApeldoornD Wiersma
Oct 27, 2015·Social Psychiatry and Psychiatric Epidemiology·S M CottonP D McGorry
Aug 1, 2012·Schizophrenia Research·Daniel SchöttleMartin Lambert
Apr 19, 2011·Schizophrenia Research·Benno G SchimmelmannMartin Lambert
Feb 9, 2011·Journal of Psychiatric Research·Daniel M BlumbergerBarnett S Meyers
Mar 9, 2010·Schizophrenia Research·Philippe ConusBenno G Schimmelmann
Nov 4, 2015·Schizophrenia Research·Marco ArmandoFrauke Schultze-Lutter
Sep 2, 2011·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Frauke Schultze-LutterBenno G Schimmelmann
Feb 20, 2014·Early Intervention in Psychiatry·Andrew TapfumaneyiUNKNOWN MiData Consortium
Jun 29, 2011·Early Intervention in Psychiatry·Thilini RajapakseRichard Fraser
Mar 3, 2012·Early Intervention in Psychiatry·Maria Teresa CascioAngelo Cocchi
Oct 10, 2013·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Paul A Tiffin, Patrick Welsh
Oct 29, 2011·Early Intervention in Psychiatry·Andrea PolariPhilippe Conus
Jun 28, 2013·Early Intervention in Psychiatry·Siann BowmanLinsey Howie
Mar 11, 2010·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Christoph U CorrellBarbara A Cornblatt
Apr 18, 2013·Journal of Psychiatric and Mental Health Nursing·S Sadeghieh AhariB Shirinzadeh
Jul 15, 2015·Social Psychiatry and Psychiatric Epidemiology·Frauke Schultze-LutterJoachim Klosterkötter
Sep 23, 2011·Schizophrenia Research·S M CottonP Conus
Dec 3, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Richie PoultonLeslie D Leve
Jul 6, 2014·Schizophrenia Research·Christian G HuberStefan Borgwardt
Mar 27, 2013·Schizophrenia Research·S M CottonP Conus
Feb 23, 2013·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Rebecca SchennachHans-Jürgen Möller
Apr 24, 2012·Psychiatry Research·Miguel Ruiz-VeguillaManuel Gurpegui
Mar 20, 2013·Journal of Psychiatric Research·Alejandra Mondragón-MayaCamilo de la Fuente-Sandoval
Mar 5, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·F Schultze-LutterJ Klosterkötter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.